Ru Zhou

5.5k citations

113 papers · 3.8k indexed · h-index 34

Impact in

Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Complementary and alternative medicine top 1%
- Natural Compounds in Disease Treatment

Papers in ⓘ

Molecular Biology 39
- Chemical Synthesis and Analysis 6
- Glycosylation and Glycoproteins Research 6
Immunology 28
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 6

Co-authors: Rachel R Caspi (7 shared papers)Peter S. Dragovich (14 shared papers)Thomas J. Prins (12 shared papers)Jianping Zuo (18 shared papers)Wei Tang (16 shared papers)Pinku Mukherjee (15 shared papers)Amy K. Patick (9 shared papers)Stephen T. Worland (9 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Cancer Research (4 papers)The Journal of Organic Chemistry (4 papers)The Journal of Immunology (3 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Ru Zhou

106 papers receiving 3.7k citations

Peers

Countries citing papers authored by Ru Zhou

Since Specialization

Citations

This map shows the geographic impact of Ru Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Zhou more than expected).

Fields of papers citing papers by Ru Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Zhou. The network helps show where Ru Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Ru Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ru Zhou Line = papers co-authored together Ru Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response The Journal of Immunology ·Jun Tang, Ru Zhou, Dror Luger, Wei Zhu, Phyllis B. Silver, Rafael S. Grajewski, Shao-Bo Su, Chi-Chao Chan, Luciano Adorini, Rachel R Caspi	2009	280
2	Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes Proceedings of the National Academy of Sciences ·David A. Matthews, Peter S. Dragovich, S. E. Webber, Shella A. Fuhrman, Amy K. Patick, L S Zalman, Thomas F. Hendrickson, Robert A. Love, Thomas J. Prins, Joseph Marakovits, Ru Zhou, Jayashree Tikhe, C. E. Ford, James W. Meador, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, M. A. Brothers, Dorothy M. DeLisle, Stephen T. Worland	1999	243
3	Ocular immune privilege F1000 Biology Reports ·Ru Zhou, Rachel R Caspi	2010	186
4	In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease Antimicrobial Agents and Chemotherapy ·Amy K. Patick, Susan L. Binford, M. A. Brothers, Raven Jackson, C. E. Ford, Matthias Diem, Fausto Maldonado, Peter S. Dragovich, Ru Zhou, Thomas J. Prins, Shella A. Fuhrman, James W. Meador, L S Zalman, David A. Matthews, Stephen T. Worland	1999	175
5	CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth Frontiers in Immunology ·Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M. Whilding, Artemis Gavrill, John Maher, Pinku Mukherjee	2019	154
6	A ∼6Ma chemical weathering history, the grain size dependence of chemical weathering intensity, and its implications for provenance change of the Chinese loess–red clay deposit Quaternary Science Reviews ·Shangfa Xiong, Zhongli Ding, Yuanjian Zhu, Ru Zhou, Haijian Lu	2010	143
7	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as l-Glutamine Replacements Journal of Medicinal Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Stephen E. Webber, Joseph Marakovits, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Clifford E. Ford, Benjamin J. Burke, Paul A. Rejto, Thomas F. Hendrickson, Tove Tuntland, Edward L. Brown, James W. Meador, Rose Ann Ferre, James E. V. Harr, Maha Kosa, Stephen T. Worland	1999	139
8	Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. PubMed ·G.-H. Yang, Ru Zhou	1994	103
9	Studies of safe maximal daily dietary selenium intake in a seleniferous area in China. I. Selenium intake and tissue selenium levels of the inhabitants. PubMed ·G.-H. Yang, Ru Zhou, S N Yin, Lan Gu, Yan Bai, Y Liu, Y Liu, Xiaodong Li	1989	95
10	IGF-binding protein-4: biochemical characteristics and functional consequences Journal of Endocrinology ·Ru Zhou, Daniela Diehl, Andreas Hoeflich, Harald Lahm, Eckhard Wolf	2003	85
11	(5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo International Immunopharmacology ·Ru Zhou, Fan Zhang, Pei‐Lan He, Wen‐Liang Zhou, Qingli Wu, Jianyi Xu, Yu Zhou, Wei Tang, Xiaoyu Li, Yifu Yang, Yuanchao Li, Jianping Zuo	2005	80
12	The Living Eye “Disarms” Uncommitted Autoreactive T Cells by Converting Them to Foxp3+ Regulatory Cells following Local Antigen Recognition The Journal of Immunology ·Ru Zhou, Reiko Horai, Phyllis B. Silver, Mary J. Mattapallil, Carlos R. Zárate-Bladés, Wai Po Chong, Jun Chen, Rachael C. Rigden, Rafael Villasmil, Rachel R Caspi	2012	76
13	Investigation of the immunosuppressive activity of artemether on T‐cell activation and proliferation British Journal of Pharmacology ·Jianxun Wang, Wei Tang, L‐P Shi, Jia Wan, Ru Zhou, Jincheng Ni, Y. W. Fu, Y‐F Yang, Yuanqing Li, Jianping Zuo	2007	72
14	Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Pfefferkorn, Jihong Lou, Martha L. Minich, Kevin J. Filipski, Mingying He, Ru Zhou, Syed Ahsanuddin Ahmed, John W. Benbow, Angel-Guzman Perez, Meihua Tu, John Litchfield, Raman Sharma, Karen Metzler, Francis Bourbonais, Cong Huang, David A. Beebe, Peter J. Oates	2009	66
15	IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses Journal of Autoimmunity ·Wai Po Chong, Reiko Horai, Mary J. Mattapallil, Phyllis B. Silver, Jun Chen, Ru Zhou, Yuri V. Sergeev, Rafael Villasmil, Chi‐Chao Chan, Rachel R Caspi	2013	65
16	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore Johnson, Edward L. Brown, Fausto C. Maldonado, Shella A. Fuhrman, L S Zalman, Amy K. Patick, David A. Matthews, Xinjun Hou, James W. Meador, Rose Ann Ferre, Stephen T. Worland	2002	63
17	Chemistry of the Pyrrolo[1,2-a]benzimidazole Antitumor Agents: Influence of the 7-Substituent on the Ability To Alkylate DNA and Inhibit Topoisomerase II Journal of Medicinal Chemistry ·Ru Zhou, Edward B. Skibo	1996	62
18	The new water‐soluble artemisinin derivative SM905 ameliorates collagen‐induced arthritis by suppression of inflammatory and Th17 responses British Journal of Pharmacology ·Jianxun Wang, Wei Tang, Ru Zhou, Jia Wan, L‐P Shi, Yongliang Zhang, Y‐F Yang, Yuanqing Li, Jianping Zuo	2008	61
19	Inhibition of S-Adenosyl-l-homocysteine Hydrolase Induces Immunosuppression Journal of Pharmacology and Experimental Therapeutics ·Qingli Wu, Yunfeng Fu, Wen‐Liang Zhou, Junxia Wang, Yonghong Feng, Jing Liu, Jianyi Xu, Pei‐Lan He, Ru Zhou, Wei Tang, Guifeng Wang, Yu Zhou, Yifu Yang, Jian Ding, Xiaoyu Li, Xiaoru Chen, Chong Yuan, Brian R. Lawson, Jianping Zuo	2005	54
20	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure−Activity Studies of Ketomethylene-Containing Peptidomimetics Journal of Medicinal Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Clifford E. Ford, James W. Meador, Rose Ann Ferre, Stephen T. Worland	1999	54

About Ru Zhou

Ru Zhou is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Organic Chemistry, having authored 113 papers that have together received 3.8k indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (9 papers), Viral Infections and Immunology Research (8 papers), CAR-T cell therapy research (7 papers), Chemical Synthesis and Analysis (6 papers), Glycosylation and Glycoproteins Research (6 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Immune Cell Function and Interaction (6 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Immunology (766 citations), Complementary and alternative medicine (250 citations), Ophthalmology (195 citations), Oncology (568 citations) and Infectious Diseases (366 citations). Ru Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Rachel R Caspi, Peter S. Dragovich, Thomas J. Prins, Jianping Zuo, Wei Tang, Pinku Mukherjee, Amy K. Patick, Stephen T. Worland, Shella A. Fuhrman and David A. Matthews. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Cancer Research, The Journal of Organic Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact